Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Syra Health FY23 EPS $(0.60) Vs $(0.70) YoY; Revenue $5.5M Vs $5.6M YoY

Author: Benzinga Newsdesk | March 25, 2024 08:47am

2023 Financial Highlights

2023 revenue of $5.5 million compared to $5.6 million in 2022.
Business units excluding Healthcare Workforce grew 250% and comprised 23% of total revenues in 2023, versus only 6% in 2022.
Population Health, driven by demand for epidemiology services, had revenues of $715,499, an increase of more than 125% compared to 2022.
Digital Health, driven by sales of the Company's SyraBot product, had revenues of $515,250 marking its first year of revenues.
Gross profit margin increased 670 bps to 25.6% compared to 18.9% in 2022.
- December 31, 2023 ending cash balance of $3.3 million and no long-term debt.

Posted In: SYRA